| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:Bortezomib Impurity 4
CAS:862894-96-0
Purity:> 95% Remarks:Bortezomib Impurity 4 is an impurity of Bortezomib.
|
| Company Name: |
Beijing Comparison Pharmaceutical Technology Co., Ltd
|
| Tel: |
010-52878169 15701683040 |
| Email: |
sales@bjcomparison.com |
| Products Intro: |
Product Name:(S)-N-(1-(3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS:862894-96-0
Purity:>=95% Package:100mg/;50mg/;25mg/;10mg/
|
| Company Name: |
ChemStrong Scientific Co.,Ltd
|
| Tel: |
0755-0755-66853366 13670046396 |
| Email: |
sales@chem-strong.com |
| Products Intro: |
Product Name:Bortezomib Impurity O
CAS:862894-96-0
Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
|
| | (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Basic information |
| Product Name: | (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide | | Synonyms: | (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;Bortezomib Impurity O;N-[(2S)-1-(3-methylbutanoylamino)-1-oxo-3-phenylpropan-2-yl]pyrazine-2-carboxamide;(S)-N-(1-(3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide? (Bortezomib Impurity）;2-Pyrazinecarboxamide, N-[(1S)-2-[(3-methyl-1-oxobutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-;Bortezomib Impurity U | | CAS: | 862894-96-0 | | MF: | C19H22N4O3 | | MW: | 354.4 | | EINECS: | | | Product Categories: | | | Mol File: | 862894-96-0.mol |  |
| | (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Chemical Properties |
| storage temp. | 2-8°C | | solubility | Chloroform (Slightly), DMSO (Sparingly), Methanol (Very Slightly) | | form | Solid | | color | White to Off-White |
| | (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Usage And Synthesis |
| Uses | N(1-(3-Methylbutanamido) N(1-Des(boric Acid)) Bortezomib is an impurity of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. |
| | (S)-N-(1-(3-MethylbutanaMido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide Preparation Products And Raw materials |
|